Vivani Medical, Inc. (VANI): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$130.0K
Year ended 2021-12-31
-70.2%
3-year compound annual growth
-58.1%
5-year compound annual growth
$10.08M2013-12-31: $5.63M2014-12-31: $3.56M2015-12-31: $5.29M2016-12-31: $10.08M2017-12-31: $5.12M2018-12-31: $4.89M2019-12-31: $2.15M2020-12-31: $500.0K2021-12-31: $130.0K$130.0K
2013-12-31 Cost of Revenue (USD) 2021-12-31
Period endedCost of RevenueChange YoYSource filing
2021-12-31$130.0K-74.0%2022-03-29, From 2021-01-01
2020-12-31$500.0K-76.8%2022-03-29, From 2020-01-01
2019-12-31$2.15M-56.0%2021-03-16, From 2019-01-01
2018-12-31$4.89M-4.5%2020-03-19, From 2018-01-01
2017-12-31$5.12M-49.2%2019-03-19, From 2017-01-01
2016-12-31$10.08M+90.4%2019-03-19, From 2016-01-01
2015-12-31$5.29M+48.8%2018-03-20, From 2015-01-01
2014-12-31$3.56M-36.8%2017-03-16, From 2014-01-01
2013-12-31$5.63Mn/a2016-03-11, From 2013-01-01